CRIS Current Research Information System

TAGLIERI, NEVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.973
AS - Asia 8.192
EU - Europa 5.946
AF - Africa 665
SA - Sud America 482
Continente sconosciuto - Info sul continente non disponibili 482
OC - Oceania 14
AN - Antartide 1
Totale 25.755
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.749
VN - Vietnam 2.711
SG - Singapore 2.104
CN - Cina 1.695
GB - Regno Unito 1.337
IT - Italia 1.023
DE - Germania 846
SE - Svezia 721
HK - Hong Kong 542
FR - Francia 387
IN - India 344
BR - Brasile 335
RU - Federazione Russa 295
IE - Irlanda 255
NL - Olanda 249
UA - Ucraina 235
CI - Costa d'Avorio 166
JP - Giappone 150
ZA - Sudafrica 140
TG - Togo 130
FI - Finlandia 123
CA - Canada 119
SC - Seychelles 108
BG - Bulgaria 102
BD - Bangladesh 100
EE - Estonia 95
KR - Corea 92
JO - Giordania 90
NG - Nigeria 77
PH - Filippine 74
CH - Svizzera 62
AR - Argentina 51
BE - Belgio 46
PL - Polonia 40
TH - Thailandia 40
MX - Messico 39
IR - Iran 36
EC - Ecuador 30
IQ - Iraq 29
AT - Austria 28
ID - Indonesia 27
TR - Turchia 27
CO - Colombia 24
TW - Taiwan 22
ES - Italia 21
SA - Arabia Saudita 19
PK - Pakistan 16
CL - Cile 15
UZ - Uzbekistan 15
LT - Lituania 14
JM - Giamaica 13
EG - Egitto 12
RO - Romania 12
AU - Australia 10
CR - Costa Rica 10
HN - Honduras 10
HR - Croazia 8
PY - Paraguay 8
VE - Venezuela 8
GR - Grecia 7
MY - Malesia 7
DK - Danimarca 6
GT - Guatemala 6
KZ - Kazakistan 6
OM - Oman 6
SV - El Salvador 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
LB - Libano 5
LV - Lettonia 5
MN - Mongolia 5
NP - Nepal 5
UY - Uruguay 5
AL - Albania 4
ET - Etiopia 4
KE - Kenya 4
PE - Perù 4
PR - Porto Rico 4
PT - Portogallo 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DZ - Algeria 3
IL - Israele 3
MA - Marocco 3
MK - Macedonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
TN - Tunisia 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
BS - Bahamas 2
HT - Haiti 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LC - Santa Lucia 2
MM - Myanmar 2
PA - Panama 2
PS - Palestinian Territory 2
Totale 25.242
Salva come PNG Salva come JPEG
Città #
Singapore 1.461
Ashburn 1.118
Southend 1.113
Fairfield 749
Chandler 707
San Jose 637
Ho Chi Minh City 628
Hanoi 563
Hong Kong 516
Santa Clara 425
Woodbridge 362
Houston 357
Wilmington 349
Seattle 328
Ann Arbor 299
Princeton 285
Cambridge 259
Council Bluffs 256
Beijing 255
Dublin 252
Boardman 215
Dong Ket 203
New York 171
Abidjan 166
Hefei 160
Los Angeles 155
Bologna 150
Jacksonville 135
Lauterbourg 130
Lomé 130
Westminster 116
Tokyo 114
Nanjing 110
Bremen 108
Padova 108
Turin 105
Berlin 98
Milan 98
Sofia 98
Da Nang 97
Dallas 91
Amman 90
Frankfurt am Main 79
Abeokuta 77
Helsinki 77
Buffalo 73
São Paulo 69
Haiphong 67
Munich 67
Chicago 62
Redondo Beach 58
Saint Petersburg 56
San Diego 54
Seoul 54
Bern 52
Changsha 50
Guangzhou 49
Brussels 45
Shenyang 44
Jinan 43
Shanghai 43
Johannesburg 41
Medford 40
Turku 40
Nanchang 39
Dearborn 38
The Dalles 38
Phoenix 36
Hebei 35
Biên Hòa 32
London 32
Can Tho 31
Toronto 31
Rome 30
Yubileyny 30
Florence 29
Jiaxing 28
Pune 28
Tianjin 28
Falkenstein 27
Mülheim 27
Warsaw 27
Quận Bình Thạnh 26
Orem 25
Atlanta 24
Paris 24
Washington 24
Zhengzhou 24
Norwalk 23
Thái Nguyên 23
Olalla 21
Shenzhen 21
Montreal 20
Mountain View 20
Des Moines 19
Düsseldorf 19
Ha Long 19
Lanzhou 19
Nuremberg 19
Redmond 19
Totale 15.962
Salva come PNG Salva come JPEG
Nome #
Cystatin C and Cardiovascular Risk 355
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 289
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 279
The role of the vascular surgeon in transcatheter aortic valve implantation 272
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 261
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 257
Detection of Tissue Factor Antigen and Coagulation Activity in Coronary Artery Thrombi Isolated from Patients with ST-Segment Elevation Acute Myocardial Infarction 251
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 245
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 243
Carbon dioxide coronary angiography: A mechanical feasibility study with a cardiovascular simulator 240
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 237
Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy. 236
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 233
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 228
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 227
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 220
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 218
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 213
Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis 213
32P brachytherapy in the treatment of complex Cypher in-stent restenosis. 212
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 212
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 212
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 210
Secondary prevention medical therapy and outcomes in patients with myocardial infarction with non-obstructive coronary artery disease 209
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 208
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 205
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 205
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 203
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 203
Inferior Q waves in apparently healthy subjects: Should we take a deep breath? An electrocardiographic, echocardiographic and cardiac magnetic resonance study 202
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 201
[Cystatin C and cardiovascular risk. 198
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 196
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 196
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 195
Prognostic Significance of Baseline White Blood Cell Count in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. 195
Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials 192
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease 192
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 191
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 191
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 190
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 189
Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction 188
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 187
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 185
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 184
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 184
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 184
What is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based access. 184
Cistatina C and rischio cardiovascolare 183
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 183
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 182
Peripheral arterial disease and long-term mortality following acute coronary syndromes: insights from a large registry of unselected patients 181
Movement compensation during carbon dioxide coronary angiography: In-vitro validation 181
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 180
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 180
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 179
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 177
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 176
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 175
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 174
Mid-term and long-term mortality associated with heart failure in patients hospitalized for acute coronary syndromes 174
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 174
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 173
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 173
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 172
Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromes 171
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 171
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 169
A rescue transcatheter solution for early sutureless basal ring infolding 168
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: The GEPRESS study 168
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 167
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 167
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 166
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 165
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 165
Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly 165
Cystatin C and cardiovascular risk. 164
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease 163
Occurrence of major bleeding during long-term follow up of unselected patients with STE vs NSTE Acute Coronary Syndromes 162
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry 162
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 162
Repeated Aortic Balloon Valvuloplasty in Elderly Patients With Aortic Stenosis Who Are Not Candidates for Definitive Treatment 160
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 160
Standard ECG to predict culprit left main disease in unselected patients with non ST-segment elevation acute coronary syndrome 160
Predictors of 32P h brachytherapy failure in patients with high-risk in-stent restenosis 160
Recapture of the Sapien-3 Delivery System After Transversal Balloon Rupture Using a Whole Percutaneous Femoral Approach 160
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 159
Effect of cerebrovascular disease on long-term outcome of patients with acute coronary syndromes: findings from a large cohort of unselected patients 159
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 159
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 158
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 158
Residual aortic regurgitation is a major determinant of late mortality after transcatheter aortic valve implantation 157
Prognostic significance of mean platelet volume on admission in unselected cohort of patients with non ST-segment elevation acute coronary syndrome 155
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 155
Randomized comparison of balloon aortic valvuloplasty performed with or without rapid cardiac pacing: The pacing versus no pacing (PNP) study 154
Diagnostic performance of standard electrocardiogramfor prediction of site of coronary occlusion in unselected anterior STEMI patients 154
Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction. 154
Correlation between aortic root dimension and coronary ectasia 154
Acute hand ischemia after radial intervention in patient with CREST-associated pulmonary hypertension: successful treatment with manual thromboaspiration. 152
Totale 19.120
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.044
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.171 0 0 145 222 204 120 49 193 85 188 518 447
2022/20233.267 268 458 176 450 268 267 77 179 593 83 281 167
2023/2024985 70 125 49 117 86 309 35 54 21 60 30 29
2024/20253.480 196 484 303 280 532 188 169 103 56 319 130 720
2025/20268.510 1.060 687 601 604 847 406 887 359 1.789 722 299 249
2026/20271.122 180 300 642 0 0 0 0 0 0 0 0 0
Totale 25.755